Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other Working Capital Changes (2021 - 2025)

Rxo (RXO) has disclosed Other Working Capital Changes for 5 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 92.86% year-over-year to $1.0 million, compared with a TTM value of -$19.0 million through Dec 2025, down 137.5%, and an annual FY2025 reading of -$19.0 million, down 137.5% over the prior year.
  • Other Working Capital Changes was $1.0 million for Q4 2025 at Rxo, up from -$27.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $14.0 million in Q1 2023 and bottomed at -$27.0 million in Q3 2025.
  • Average Other Working Capital Changes over 5 years is -$2.2 million, with a median of -$1.0 million recorded in 2022.
  • The sharpest move saw Other Working Capital Changes surged 1500.0% in 2023, then plummeted 425.0% in 2024.
  • Year by year, Other Working Capital Changes stood at -$10.0 million in 2021, then surged by 80.0% to -$2.0 million in 2022, then surged by 150.0% to $1.0 million in 2023, then skyrocketed by 1300.0% to $14.0 million in 2024, then tumbled by 92.86% to $1.0 million in 2025.
  • Business Quant data shows Other Working Capital Changes for RXO at $1.0 million in Q4 2025, -$27.0 million in Q3 2025, and -$3.0 million in Q2 2025.